• The Department of Urology of the Jewish General Hospital, a McGill University afiliated hospital, presents the Third Montréal Conference on Innovative Therapies for Prostate Cancer.

  • The two-day conference will include state-of-the-art and didatic lectures, debate between experts in challenging questions, and panel discussions along with podium and poster presentations.

  • The Third Montréal Conference of Innovative Therapies for Prostate Cancer will welcome a wide variety of specialized particitpants.

Target Audience

The Montréal Conference on Innovatives Therapies for Prostate Cancer will welcome all those interested in this new field:

  • urologists,
  • radiation oncologists,
  • medical oncologists,
  • radiologists,
  • pathologists,
  • engineers,
  • molecular biologists,
  • industry leaders,
  • other health professionals

The Venue

Montréal Marriott Château Champlain

1 Place du Canada
Montréal, Québec H3B 4C9

Marriott Château Champlain
Guest Speakers

united states

Dr. Kim Chi

Systemic therapy in high-risk localized prostate cancer: beyond Androgen Ablation



Dr. Joseph Chin

Image-directed therapy – update on transurethral ultrasound therapy


united states

Dr. James Eastham
The evolving role of surgery: can surgery be enough in the face of high grade extraprostatic disease?

Mark Emberton

 united kingdom

Dr. Mark Emberton
Consequences intended and otherwise of an image-based pathway in prostate cancer

Fred Saad


Dr. Fred Saad
Improving outcome in CRPC with bone targeted therapy and other novel therapeutics

Complete List of Guest Speakers

Hosts      Logo
an event produced by